Does DUPILUMAB Cause Upper respiratory tract infection? 902 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 902 reports of Upper respiratory tract infection have been filed in association with DUPILUMAB (Dupixent). This represents 0.2% of all adverse event reports for DUPILUMAB.
902
Reports of Upper respiratory tract infection with DUPILUMAB
0.2%
of all DUPILUMAB reports
1
Deaths
89
Hospitalizations
How Dangerous Is Upper respiratory tract infection From DUPILUMAB?
Of the 902 reports, 1 (0.1%) resulted in death, 89 (9.9%) required hospitalization, and 3 (0.3%) were considered life-threatening.
Is Upper respiratory tract infection Listed in the Official Label?
Yes, Upper respiratory tract infection is listed as a known adverse reaction in the official FDA drug label for DUPILUMAB.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Upper respiratory tract infection?
ADALIMUMAB (3,306)
ETANERCEPT (2,948)
TOFACITINIB (1,805)
RITUXIMAB (1,713)
ABATACEPT (1,623)
METHOTREXATE (1,576)
TOCILIZUMAB (1,455)
APREMILAST (1,437)
PREDNISONE (1,354)
SECUKINUMAB (1,339)
Which DUPILUMAB Alternatives Have Lower Upper respiratory tract infection Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE